Clinical trials
Withdrawn Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2009 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Masonic Cancer Center, University of Minnesota | 2 |
| University of Michigan Rogel Cancer Center | 2 |
| Baptist Health South Florida | 1 |
| Bellicum Pharmaceuticals | 1 |
| Bio-Path Holdings, Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Fred Hutchinson Cancer Center | 1 |
| M.D. Anderson Cancer Center | 1 |
| Mayo Clinic | 1 |
| Naoyuki G. Saito, M.D., Ph.D. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 15 |
| Leukemia, Myeloid, Acute | 7 |
| Myelodysplastic Syndromes | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Hematologic Neoplasms | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Blast Crisis | 2 |
| Hematologic Diseases | 2 |
| Hodgkin Disease | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.